https://socictopen.socict.org/files/original/71d56942ba09e8e68456d453befc86d3.pdf 6b6ef2361de5b8699331f98a8cdaaa31 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis Creator An entity primarily responsible for making the resource Jane Oba, Karoline Soares Garcia, Bruna Damásio Moutinho, Matheus Freitas Cardoso de Azevedo, Natalia Sousa Freitas Queiroz, Luciane Reis Milani, Lucas Navarro Sanches, Luisa Leite Barros, Alexandre de Sousa Carlos, Aderson Omar Mourão Cintra Damião, Aytan Miranda Sipahi Description An account of the resource Introduction: The coronavirus disease 2019 (COVID-19) pandemic has increased concern regarding SARS-CoV-2 infection in inflammatory bowel disease (IBD) patients, especially those on immunosuppressive therapies or with active disease. There are limited reports describing the clinical features of COVID-19 in an IBD population, and the impact of immunosuppression on the severity of the infection remains unclear. Case Report: A 33-year-old female patient with a long history of ulcerative colitis, poorly controlled, was admitted with COVID-19 a few days after being discharged from the hospital for treatment of acute severe ulcerative colitis. High-risk factors for COVID-19 complications, i.e., high-dose steroids (40 mg prednisone) and severe active disease, were present at admission. Despite the development of extensive pulmonary involvement, the patient had a favorable outcome. Discussion: Management of IBD patients during the COVID-19 pandemic has been challenging. Measures to minimize the potential risk of SARS-CoV-2 infection, including strict social distancing and self-isolation, in the IBD population have been recommended, especially for high-risk patients. Although steroid tapering and persistence of biologics are advised by professional groups, the best treatment strategy for IBD patients presenting a flare during the outbreak has yet to be defined. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource inflammatory bowel disease, ulcerative colitis, colitis, coronavirus infections, COVID-19 Identifier An unambiguous reference to the resource within a given context DOI: 10.1159/000508161 Source A related resource from which the described resource is derived Inflammatory Intestinal Diseases Publisher An entity responsible for making the resource available Karger Publishers Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Diseases of the digestive system. Gastroenterology